Percutaneous Therapies for Hepatocellular Carcinoma: Evolution of Liver Directed Therapies

Percutaneous ablation is a mainstay of treatment for early stage, unresectable hepatocellular carcinoma (HCC). Recent advances in technology have created multiple ablative modalities for treatment of this common malignancy. The purpose of this review is to familiarize readers with the technical and...

Descripción completa

Detalles Bibliográficos
Autores principales: Huber, Timothy C, Bochnakova, Teodora, Koethe, Yilun, Park, Brian, Farsad, Khashayar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476177/
https://www.ncbi.nlm.nih.gov/pubmed/34589446
http://dx.doi.org/10.2147/JHC.S268300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476177/
https://www.ncbi.nlm.nih.gov/pubmed/34589446
http://dx.doi.org/10.2147/JHC.S268300

Ejemplares similares